Use of N- (dibenz (b, f) oxepin-10-ylmethyl) -N-methyl-N-prop-2-ynylamine (OMIGAPIL) for the prophylaxis and / or treatment of congenital muscular dystrophy or myopathy due to collagen VI deficiency

• 收藏
• 分享

专利权人:

SANTHERA PHARMACEUTICALS (SCHWEIZ) AG

发明人:

MEIER, THOMAS

申请号：

DK07724008

公开号：

DK2004176T3

申请日:

2007.04.04

申请国别(地区):

DK

年份:

2012

代理人:

摘要：

The invention relates to the use of a compound of the formula (I) or a pharmaceutically acceptable addition salt thereof for the preparation of a medicament for the prophylaxis and/or treatment of muscular dystrophies or myopathies resulting from mutations in genes encoding for collagen VI.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/